Asensus Surgical Inc. buy krebskrebs
Start price
17.05.21
/
50%
€1.42
Target price
17.05.22
€2.00
Performance (%)
-73.34%
End price
18.05.22
€0.38
Summary
This prediction ended on 18.05.22 with a price of €0.38. The BUY prediction by krebskrebs for Asensus Surgical Inc. performed very badly with a performance of -73.34%. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Asensus Surgical Inc. | - | - | - | - |
| iShares Core DAX® | -0,68 % | 4,05 % | 2,21 % | 52,79 % |
| iShares Nasdaq 100 | 0,99 % | 10,87 % | 38,04 % | 94,87 % |
| iShares Nikkei 225® | 3,28 % | 13,47 % | 59,00 % | 70,29 % |
| iShares S&P 500 | 0,62 % | 6,20 % | 26,15 % | 68,91 % |
Comments by krebskrebs for this prediction
In the thread Transenterix Inc diskutieren
Buy mit Kursziel 2,0
In the thread Trading Transenterix Inc.
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten

